News chronological

Showing 10 items since 1054457

THEFEDERALIST (Jordan Boyd) - Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women

The FDA appears to be slow-walking its mifepristone review, frustrating Trump allies in both Congress and pro-life states.

AMERICANGREATNESS (Russ Walker and Shay Khatiri) - Big Brother Is Here, and It’s China

Over the past decade, many Americans have voluntarily shared their private lives and personal information with the Chinese government through digital platforms and connected devices. […] Source

AMERICANGREATNESS (Steven Crenshaw) - A Prescription for Disaster: Saving TrumpRx From State Legislation

The launch of TrumpRx.gov is the latest and most important example of the president’s promise to Make America Healthy Again (MAHA). The platform offers discounts […] Source

AMERICANGREATNESS (Liz Sheld) - Morning Greatness: Trump to Deliver State of the Union Tuesday Evening

Good Tuesday morning. Here is what’s on President Trump’s agenda today:  9:00 AM THE PRESIDENT participates in Executive Time 12:30 PM THE PRESIDENT participates in […] Source

AXIOS (Caitlin Owens) - The biggest challenge to Trump's drug price claims? Reality

As the White House gears up its election-year pitch taking credit for lowering prescription drug prices, it faces a key unknown: Will voters notice any difference? Why it matters: One of President Trump's primary answers to concerns about affordability may fall on deaf ears if patients don't see results — and policy experts have warned many won't. Driving the news: Trump will almost certainly point to his pricing deals with leading drugmakers during Tuesday's State of the Union, along with the launch of TrumpRx, a direct-to-consumer sales platform. - The White House is preparing to make health care central to its midterms pitch, CNN recently reported , and has urged congressional Republicans to codify its "most favored nation" policies…

As the White House gears up its election-year pitch taking credit for lowering prescription drug prices, it faces a key unknown: Will voters notice any difference? Why it matters: One of President Trump's primary answers to concerns about affordability may fall on deaf ears if patients don't see results — and policy experts have warned many won't. Driving the news: Trump will almost certainly point to his pricing deals with leading drugmakers during Tuesday's State of the Union, along with the launch of TrumpRx, a direct-to-consumer sales platform. - The White House is preparing to make health care central to its midterms pitch, CNN recently reported , and has urged congressional Republicans to codify its "most favored nation" policies…Open